---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-21-007247"
form_type: "8-K"
ticker: "UEEC"
cik: "0001096938"
company_name: "United Health Products, Inc."
filed_at: "2021-10-14T23:59:59+00:00"
generated_at: "2026-06-28T20:45:58.637373+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# United Health Products updates on FDA PMA process and Triton Funds investment

## Summary
- FDA requested details on HemoStyp manufacturing process; UHP implemented GMP software tool and will respond later this month.
- SEC declared UHP's registration statement effective on September 29, allowing closure of $4M-$6M stock purchase with Triton Funds.
- UHP produced a prototype of new HemoStyp format for trauma/surgical applications; further testing planned.
- Company will host investor information session on October 15, 2021 at 9am ET.

## SEC filing metadata
- accession: 0001477932-21-007247
- form_type: 8-K
- ticker: UEEC
- cik: 0001096938
- company_name: United Health Products, Inc.
- filed_at: 2021-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1096938/000147793221007247/0001477932-21-007247-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1096938/000147793221007247/ueec_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-21-007247
- JSON: https://secwatch.observer/filing/0001477932-21-007247.json
- Plain text: https://secwatch.observer/filing/0001477932-21-007247.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.